Adamax
Adamantane-Semax · Adamantyl-Semax
Adamantane-modified Semax analog sold as a nasal research spray. Search volume is real; dedicated papers are essentially absent. Treat every half-life and dose number as vendor folklore unless a citation appears. Parent Semax evidence does not automatically transfer to an adamantyl conjugate.
Quick answer
What it is: Adamantane-modified Semax analog sold as a nasal research spray.
Typical research dose: 200-600 mcg/day (intranasal; vendor protocols only)
Research summary, not medical advice.
Use-case scores
- Cognition2.5/10
Compound card
- Sequence
- Adamantane-conjugated Semax (vendor structure; confirm COA)
- Class
- Uncharacterized Semax conjugate
- Formula
- Adamantyl-Semax (vendor structure; confirm COA)
- Status
- Not FDA-approved · research use
How it works
Adamax is marketed as adamantane-conjugated Semax. Adamantane is a real lipophilicity/stability trick in medicinal chemistry. Transferring Semax’s BDNF papers onto this conjugate without PK is a category error.
We list it because people search it and vendors sell it. Half-life on this page is explicitly unknown.
Source: Parent compound: Semax. Adamax: no indexed human PK as of 2026.
No published human PK
Dose and duration numbers on vendor pages are not citations. If you need evidence, read Semax and treat this as an uncharacterized analog.
Research Use Cases
- ✓Nootropic analog SKU: Low
Dosing
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Vendor nasal range only | 200–600 mcg/day | 1–2× daily | Folklore until a paper exists. |
Administration
Timeline
Who it is for
Nootropic analog SKU
LowHigh search, near-zero papers. Listed for identity and recon, not endorsement.
Reconstitution
Safety & Considerations
Unknown human safety file. Nasal irritation possible. Adamantane moieties have their own CNS/renal baggage in other drugs - not characterized here.
Regulatory & Legal Status
Adamantane-Semax analog. No indexed human PK or approval
Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Limits of current evidence
- No published human PK on this leaf.
- Dose numbers on vendor pages are not citations.
Verdict
Adamax is a vendor conjugate. Adamantane is real chemistry. Semax papers are not this molecule’s papers.
Interactions & Contraindications
Unknown human safety file. Nasal irritation possible. Adamantane moieties have their own CNS/renal baggage in other drugs - not characterized here.
Adamax vs. Semax
Canonical comparison: Adamax vs Semax
| Attribute | Adamax | Semax |
|---|---|---|
| Structure | Adamantane-Semax (vendor) | ACTH 4–10 heptapeptide |
| Human PK | None indexed | Russian clinical literature |
| Evidence level | Low | Low–moderate (parent drug in Russia) |
Verdict: Adamax is a search term and a SKU. Semax is the molecule with papers. Do not copy Semax onset onto Adamax.
Frequently Asked Questions
Does Adamax last longer than Semax?▼
Prescription options: compare licensed telehealth providers
Some peptide therapies are available only by prescription after a consult with a licensed clinician.
